Back to search

Netherlands· NL-e54f7d3b9c32

Orladeyo 132 mg filmomhuld granulaat in sachet

A berotralstat product containing berotralstatdihydrochloride, registered in Netherlands by BioCryst Ireland Limited. The same ATC class is registered in 17 of our 19 countries.

ATC B06AC06

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedOrladeyo 132 mg filmomhuld granulaat …ATCB06AC06REGISTER NO.NL-e54f7d3b9c32PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Berotralstat is registered in 17 of 19 countries.

Countries holding a registration under ATC B06AC06 (berotralstat), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 11 of them publish a price we can compare per daily dose

Berotralstat · ATC B06AC06

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of berotralstat costs, country by country.

Normalised to the WHO defined daily dose (0.15 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Berotralstat · price per daily dose (0.15 g)

USD · FX 28 Sept 2026

  • CH Switzerland$576.89
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
BEROTRALSTATDIHYDROCHLORIDE
Manufacturer
BioCryst Ireland Limited
Country
Netherlands (NL)
ATC code
B06AC06
ATC class
Berotralstat
Defined daily dose
0.15 g, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/21/1544

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

209 interactions on record for berotralstat.

Graded by severity as the source publishes them — 66 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Berotralstat · interactions on record

209 records

  • 66 severe
  • 132 moderate
  • 11 minor

Most severe, free to view

  • RolapitantA04AD14severe
  • NaloxegolA06AH03severe
  • FidaxomicinA07AA12severe
  • EliglustatA16AX10severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Berotralstat in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All berotralstat products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Orladeyo
  • Liechtenstein · Orladeyo
  • Norway · Orladeyo

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/38de0f9a-7f5c-4b06-a9e8-e263b370a75f
GET /v1/drugs/38de0f9a-7f5c-4b06-a9e8-e263b370a75f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhuld granulaat",
  "route": "Oraal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/orladeyo-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Berotralstat",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp135283",
  "excipients": [
    "BASISCH GEBUTYLEERD METHACRYLAAT COPOLYMEER (E 1205)",
    "CROSPOVIDON TYPE A",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MAÏSZETMEEL, GEPREGELATINEERD",
    "NATRIUMLAURILSULFAAT",
    "SILICIUMDIOXIDE (E 551)",
    "STEARINEZUUR (E 570)",
    "TALK (E 553b)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "BEROTRALSTATDIHYDROCHLORIDE"
  ],
  "leaflet_url": null,
  "authorised_at": "2021/04/30",
  "procedure_number": "EMEA/H/C/005138",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/21/1544",
  "additional_monitoring": "N"
}

See everything about berotralstat.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.